The wearable device can measure SpO₂ anywhere and anytime. It can raise a warning when the device detects blood oxygen level is low. Test SpO₂ might not regard as the golden rule for diagnosis. However, it becomes a basis for discovering risks in advance and managing health independently.

AECG100 is the first tester designed for verifying wearable reflectance pulse oximeter globally. Develop R curves of the device under test (DUT) for SpO₂ monitors' verification and validation testing. The SpO₂ test mode is based on the theory of pulse oximetry the innovative simulator to output ECG and PPG analog signals simultaneously. Adjustable time difference parameters to generate various Pulse Wave Transit Time (PWTT) signals. Ensure that the product can be in the R&D、QA、QC stage to verification, quality assurance, and the overall system performance of the clinical trial test before.  Standard Coverage: IEC 60601-2-47, China YY0885. Applicable for R&D, compliance, and production line testing.

                                         AECG100-PPG-1R-525   

                                    AECG100-PPG-2R-880/940

Product Features

■  PPG-1R-525 module offers optical waveforms simulating
    PPG heart rate signals
■  PPG-2R-880 and PPG-2R-940 modules offer red and infrared optical
    waveforms for SpO₂ testing
■  Adjustable PWTT parameters allow user to check and improve
    the algorithm of blood pressure applications
■  Developing R curves of the device under test (DUT) for SpO₂ monitors'
    verification and validation testing